Covered recipient · General Payments record
KALAISELVI RAJENDRAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2025
$1,279.08
- Reported across 40 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.55 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $76.33 | 4 |
| Teva Pharmaceuticals USA, Inc. | $36.06 | 2 |
| Vanda Pharmaceuticals Inc. | $28.35 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.08 | 1 |
| Luye Pharma (USA) Ltd. | $18.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.20 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184799620 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.70 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184799664 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184799704 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.15 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184799726 | CMS |
| Luye Pharma (USA) Ltd. | $18.73 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245072610 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.08 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227461747 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.56 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247386168 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.50 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247386300 | CMS |
| Vanda Pharmaceuticals Inc. | $28.35 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232996180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.